Skip to content

A Study on the Effect of Plant-Derived Products on gut microbiome -A Randomized, Double-blind, Placebo-controlled, Parallel-group Study-

A Study on the Effect of Plant-Derived Products on gut microbiome -A Randomized, Double-blind, Placebo-controlled, Parallel-group Study- - A Study on the Effect of Plant-Derived Products on gut microbiome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000043006
Enrollment
60
Registered
2021-01-22
Start date
2021-01-23
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Sponsors

KSO Corporation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)Healthy males and females aged 20 to 64 years-old who defecate three to five a week. (2)Subjects who do not habitually consume a large amounts of alcohol. (3)Subjects who regularly eat three meals a day. (4)Subjects who can make self-judgment and are voluntarily giving written informed consent.

Exclusion criteria

Exclusion criteria: Subjects (who) (1)regularly use intestinal and constipation drugs (including laxatives). (2)can't stop intake food containing viable bacteria such as Lactic acid bacteria, Bifidobacteria, Natto bacteria and/or enhanced with oligosaccharide, dietary fiber and/or the health food to relieve constipation (including Food for Specified Health Uses or Foods with Function Claims) and/or containing a large amount of sugar alcohol during this study. (3)regularly eat foods containing lactic acid bacteria, bifidobacteria, and/or oligosaccharides to relieve constipation. (4)used antibiotics within the last 2 weeks prior to the screening. (5)have a history and/or a surgical history of digestive disease affecting digestion and absorption. (6)have been diagnosed irritable bowel syndrome or inflammatory bowel disease. (7)have any food allergies. (8)have excessive alcohol intake more than approximately 20 g / day of pure alcohol equivalent or habit of drinking more than 4 days a week. (9)can't stop drinking from 2 days before each measurement. (10)are shiftworker and/or midnight-shift worker. (11)contract or are under treatment for serious diseases (e.g., liver disease, kidney disease, digestive disease, heart disease, respiratory disease, endocrine disease, thyroid disease, adrenal disease and/or metabolic disease). (12)with greatly disturbed menstrual cycle. (13)plan to become pregnant after informed consent, pregnant or lactating. (14)have donated over 200 mL of blood and/or blood components within the last 1 month or over 400 mL of blood and/or blood components within the last 3 months prior to the study. (15)are under treatment for or have a history of drug addiction and/or alcoholism. (16)plan to participate in other clinical studies during test periods and/or had participated in other clinical studies within the last one month. (17)are judged unsuitable for the study by the screening. (18)are judged unsuitable for the study by the investigator for other reasons.

Design outcomes

Primary

MeasureTime frame
gut microbiome

Secondary

MeasureTime frame
Defecation questionnaire, Conditioning questionnaire

Countries

Japan

Contacts

Public ContactYoshika Komori

KSO Corporation Sales department

yoshi@kso.co.jp03-3452-7733

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026